Financial Metrics Check: Soleno Therapeutics Inc (SLNO)’s Ratios for Trailing Twelve Months

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

As of close of business last night, Soleno Therapeutics Inc’s stock clocked out at $49.03, up 4.99% from its previous closing price of $46.70. In other words, the price has increased by $4.99 from its previous closing price. On the day, 1.12 million shares were traded. SLNO stock price reached its highest trading level at $50.13 during the session, while it also had its lowest trading level at $46.11.

Ratios:

To gain a deeper understanding of SLNO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.68 and its Current Ratio is at 15.68. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.

On December 02, 2024, Stifel reiterated its Buy ratingand also kept the price unchanged to $74.

Robert W. Baird reiterated its Outperform rating for the stock on December 02, 2024, and also maintained the target price at $72.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 02 ’25 when Yen Kristen sold 2,520 shares for $45.41 per share. The transaction valued at 114,431 led to the insider holds 78,945 shares of the business.

Yen Kristen sold 2,340 shares of SLNO for $108,053 on Jan 03 ’25. The insider now owns 76,605 shares after completing the transaction at $46.18 per share. On Jan 02 ’25, another insider, Mackaness James H, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 4,083 shares for $45.41 each. As a result, the insider received 185,406 and left with 115,089 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLNO now has a Market Capitalization of 2248383488 and an Enterprise Value of 2009772032.

Stock Price History:

The Beta on a monthly basis for SLNO is -2.02, which has changed by 0.12816381 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, SLNO has reached a high of $60.92, while it has fallen to a 52-week low of $36.61. The 50-Day Moving Average of the stock is 4.03%, while the 200-Day Moving Average is calculated to be 1.42%.

Shares Statistics:

It appears that SLNO traded 512.79K shares on average per day over the past three months and 728350 shares per day over the past ten days. A total of 45.70M shares are outstanding, with a floating share count of 33.47M. Insiders hold about 27.00% of the company’s shares, while institutions hold 90.57% stake in the company. Shares short for SLNO as of 1740700800 were 4807491 with a Short Ratio of 9.38, compared to 1738281600 on 4348846. Therefore, it implies a Short% of Shares Outstanding of 4807491 and a Short% of Float of 15.529999.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular